A Pilot Genome-Wide Association Study in Postmenopausal Mexican-Mestizo Women Implicates the RMND1/CCDC170 Locus Is Associated with Bone Mineral Density
Table 3
Comparison of SNP effect sizes for BMD between GEFOS genome-wide meta-analysis and this study.
GEFOS genome-wide meta-analysisa
This study
SNP
Locus
Gene
Beta
value
Proxy SNP
Beta
value
Femoral neck BMD
rs1026364
3q13.2
KIAA2018
0.03
8.86 × 10−7
rs9813630
0.018
0.046
rs4869742
6q25.1
CCDC170
−0.05
3.14 × 10−13
rs4870044
−0.025
0.0007
rs3801387
7q31.31
WNT16
−0.08
2.78 × 10−33
rs3779381
−0.025
0.007
rs13245690
7q31.31
CPED1
0.02
8.20 × 10−4
rs13245690
0.021
0.026
rs7108738
11p15.2
SOX6
−0.08
3.52 × 10−26
rs7128738
−0.029
0.001
rs227584
17q21.31
C17orf53
−0.06
3.15 × 10−18
rs227584
−0.016
0.037
Lumbar spine BMD
rs7584262
2p21
PKDCC
0.01
0.05
rs11887431
0.057
0.0006
rs344081
3q25.31
LEKR1
0.05
1.49 × 10−8
rs344081
0.043
0.032
rs3801387
7q31.31
WNT16
−0.11
6.38 × 10−51
rs3779381
−0.036
0.005
rs13245690
7q31.31
CPED1
0.05
1.65 × 10−11
rs13245690
0.031
0.020
rs7108738
11p15.2
SOX6
−0.03
5.76 × 10−5
rs7128738
−0.030
0.021
aData of effect sizes for the SNP and BMD site (stage 1 + stage 2) were obtained from Supplemental Table S, Estrada et al. [16]. Bold indicates values > 0.001 ().